AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

Gasdermin C activation boosts type II immunity against helminths, and NSAIDs may someday offer a novel, repurposed treatment ...

Three applications for gene editing in conservation are restoring lost variation and facilitated adaptation as well as reducing harmful mutations.

Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.